Relapses in the Guillain-Barré syndrome after treatment with intravenous immune globulin or plasma exchange
Autor(es): Romano J G,Rotta F T,Potter P,Rosenfeld V,Santibanez R,Rocha B,Bradley W G
Resumo: To clarify the question of whether Guillain-Barré syndrome (GBS) patients treated with intravenous immune globulin (i.v.IG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving i.v.IG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with i.v.IG as opposed to those treated with PE.
Imprenta: Muscle & Nerve, v. 21, n. 10, p. 1327-1330, 1998
Descritores: Guillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Public health
Data de publicação: 1998
